Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity
- PMID: 10955329
Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity
Abstract
Objective: To identify predictors of short term mortality in systemic lupus erythematosus (SLE) in terms of time dependent clinical indicators of disease activity from the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI).
Methods: We studied data collected on patients followed at the University of Toronto Lupus Clinic. Clinical and laboratory indicators of disease activity are recorded at each clinic visit and a SLEDAI summary score is calculated. Survival analyses were conducted in which the prognostic value of the time dependent indicators of disease activity was examined on 6-month mortality through a multivariate Cox regression model. Relative risks, confidence intervals, and significance levels were obtained for each indicator to reflect their clinical importance and statistical significance.
Results: The sample consisted of 806 patients followed for a median of 6.6 years; 702 (87%) were female, 671 (83%) were Caucasian, and the mean age at first clinic visit was 36 years. Seventy-two patients died within 6 months of their last clinic visit. In a univariate regression model, a categorical variable reflecting total SLEDAI score was highly prognostic for mortality (p < 0.001) and yielded increasing relative risks of 1.28 for SLEDAI 1-5 vs 0, 2.34 for SLEDAI 6-10 vs 0, 4.74 for SLEDAI 11-19 vs 0, and 14.11 for SLEDAI > 20 vs 0. In a separate multivariate Cox model examining the individual components of SLEDAI, presence of organic brain syndrome, retinal changes, cranial nerve involvement, proteinuria, pyuria, pleurisy, fever, thrombocytopenia, and leukopenia each significantly increased the risk of death, while new rash and anti-DNA antibodies conferred protective effects.
Conclusion: This time dependent Cox regression analysis identified the extent to which SLE disease activity, revealed by SLEDAI, is prognostic for short term mortality. Further, important individual components were identified and their prognostic value for death was estimated.
Similar articles
-
Summarizing disease features over time: II. Variability measures of SLEDAI-2K.J Rheumatol. 2007 Feb;34(2):336-40. Epub 2006 Dec 15. J Rheumatol. 2007. PMID: 17183620
-
Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.Lupus. 2009 Aug;18(9):848-55. doi: 10.1177/0961203309103410. Lupus. 2009. PMID: 19578112
-
Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus.J Rheumatol. 2003 Sep;30(9):1977-82. J Rheumatol. 2003. PMID: 12966601
-
Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients.J Rheumatol. 1991 Aug;18(8):1180-4. J Rheumatol. 1991. PMID: 1941820 Review.
-
The incidence and prevalence of systemic lupus erythematosus in Thrace, 2003-2014: A 12-year epidemiological study.Lupus. 2016 Jan;25(1):102-9. doi: 10.1177/0961203315603141. Epub 2015 Sep 7. Lupus. 2016. PMID: 26345673 Review.
Cited by
-
Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI).Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S37-46. doi: 10.1002/acr.20572. Arthritis Care Res (Hoboken). 2011. PMID: 22588757 Free PMC article. Review. No abstract available.
-
Macular and peripapillary vessel density alterations in a large series of patients with systemic lupus erythematosus without ocular involvement.Graefes Arch Clin Exp Ophthalmol. 2022 Nov;260(11):3543-3552. doi: 10.1007/s00417-022-05742-2. Epub 2022 Jul 6. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35792929
-
Prevalence, clinical features, risk factors, and outcomes of SLE patients with aortic aneurysm: a cross-sectional retrospective study in a Chinese single center.Clin Rheumatol. 2022 Feb;41(2):377-386. doi: 10.1007/s10067-021-05927-w. Epub 2021 Oct 5. Clin Rheumatol. 2022. PMID: 34609662
-
2020 Chinese Guidelines for the Diagnosis and Treatment of Systemic Lupus Erythematosus.Rheumatol Immunol Res. 2020 Dec 1;1(1):5-23. doi: 10.2478/rir-2020-0009. eCollection 2020 Dec. Rheumatol Immunol Res. 2020. PMID: 36465077 Free PMC article.
-
The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis.Semin Nephrol. 2015 Sep;35(5):455-64. doi: 10.1016/j.semnephrol.2015.08.007. Semin Nephrol. 2015. PMID: 26573548 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical